This reluctance is likely to be at least partially attributable to the fact that, until recently, all GLP-1RAs were available as subcutaneous (s.c.) injections, given twice daily (exenatide [13]), once daily (lixisenatide [14] and liraglutide [15]), or once weekly (semaglutide [16], dulaglutide [17], and exenatide extended release [18]), a route that may be less preferable to some patients compared with oral administration [1, 19]
Getting Started with Retatrutide: The Complete Beginner's Guide You've got your retatrutide vials, your bacteriostatic water, and your insulin syringes
For more information, call 1-833-807-MJRO (833-807-6576) or go to www.mounjaro.com
If medication is prescribed, it will be sent to your pharmacy of choice
Managing Side Effects Some patients may experience side effects such as nausea or gastrointestinal discomfort, especially when first starting semaglutide GLP-1